NCT07782619 Agreement of Two OCT Biometers: A Pilot Study
| NCT ID | NCT07782619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alcon Research |
| Condition | Anterior Segment of Eye |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-08-17 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-08-17 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the measurements obtained with two different biometers, UNITY Dx and Anterion. In eye care, a biometer is a device that uses laser technology to take highly precise measurements of the eye's internal structures. It is most frequently used to help determine the exact power of the intraocular lens (IOL) needed before cataract removal.
Eligibility Criteria
Inclusion Criteria: * Have healthy, clear corneas for the normal cohort; * Have documented keratoconus for the keratoconus cohort; * Have reported use of daily contact lens use for the contact lens cohort; * Have documented dry eye, consisting of signs and symptoms for the dry eye cohort; * Has had previous keratorefractive surgery for the post-refractive surgery cohort; * Able to comprehend and sign the informed consent form. Exclusion Criteria: * Active ocular infection or inflammation; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.
Contact & Investigator
Clinical Trial Lead, Surgical
STUDY DIRECTOR
Alcon Research, LLC
Frequently Asked Questions
Who can join the NCT07782619 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Anterior Segment of Eye. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07782619 currently recruiting?
Yes, NCT07782619 is actively recruiting participants. Contact the research team at alcon.medinfo@alcon.com for enrollment information.
Where is the NCT07782619 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07782619 clinical trial?
NCT07782619 is sponsored by Alcon Research. The principal investigator is Clinical Trial Lead, Surgical at Alcon Research, LLC. The trial plans to enroll 50 participants.